As of Feb 08
| -0.27 / -5.77%|
The 1 analysts offering 12-month price forecasts for Adamis Pharmaceuticals Corp have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +262.81% increase from the last price of 4.41.
The current consensus among 1 polled investment analysts is to Buy stock in Adamis Pharmaceuticals Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.